Merck KGaA (OTCMKTS:MKGAF) Sees Large Volume Increase – Still a Buy?

Merck KGaA (OTCMKTS:MKGAFGet Free Report) shares saw unusually-high trading volume on Friday . Approximately 466 shares were traded during trading, a decline of 17% from the previous session’s volume of 559 shares.The stock last traded at $124.1180 and had previously closed at $124.9140.

Merck KGaA Trading Up 3.5%

The company has a fifty day simple moving average of $148.51 and a two-hundred day simple moving average of $139.58. The company has a market capitalization of $16.71 billion, a P/E ratio of 19.74 and a beta of 0.96. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84.

Merck KGaA Company Profile

(Get Free Report)

Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.

The company’s operations are organized mainly into three businesses.

Featured Stories

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.